2013 Environment Safety Treatment 
Cannabis Law Report
AUGUST 12, 2021
Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. 50/2013 Coll. This regulative environment also promotes economic growth and significant medical benefits, boosting consumer safety and accessibility.
The Cannigma
JUNE 15, 2021
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Alchimia
MARCH 16, 2016
Although a balanced nutrition – and regular brain stimulation – can have protective and preventive effects , we still don’t have any effective treatment for Alzheimer’s disease once it is active. Cannabinoids for treatment of Alzheimer?s Published in Current Alzheimer Research , March 2013.
Cannabis Law Report
SEPTEMBER 23, 2019
The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.
Cannabis Law Report
JANUARY 10, 2020
In addition, the United States Postal Inspection Service has noted a rise of parcels containing marijuana from Colorado mailed to other states of 207 parcels before legalization in 2013 to 1,009 parcels in 2017. 2013, August 29) Guidance Regarding Marijuana Enforcement. Marijuana Deep Dive. Retrieved from [link]. 2019, October 16).
Cannabis Law Report
OCTOBER 29, 2019
ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.
SpeedWeed
JULY 30, 2021
Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . in 2013 to 35.9% Neither the Colorado rate of use nor the national rate experienced significant changes from 2013 to 2019, according to the report. 10, 2012, when Gov.
Expert insights. Personalized for you.
59 
Let's personalize your content